BPC-157 + TB-500 Blend
Preclinical ResearchBPC-157 + TB-500 Blend
The most popular healing stack in the peptide research community. Combines BPC-157's localized healing with TB-500's systemic repair for comprehensive recovery support.
Dose
250-500 mcg BPC-157 and 250-500 mcg TB-500 per injection
Route
SubQ injection
Cycle
4-8 weeks
Storage
Store lyophilized powder refrigerated (2-8°C) away from light.
What is BPC-157 + TB-500 Blend?
The BPC-157 + TB-500 Blend is a synergistic peptide combination commonly discussed in research for its comprehensive regenerative and healing properties. BPC-157, a gastric pentadecapeptide, is explored for its organoprotective effects, wound healing, and angiogenesis-promoting activities, particularly in gastrointestinal, musculoskeletal, and neurological contexts. TB-500, a synthetic variant of the naturally occurring protein Thymosin Beta-4, is researched for its role in cell migration, angiogenesis, inflammation modulation, and tissue repair throughout the body. When combined, these peptides are hypothesized to offer a broader spectrum of therapeutic benefits, addressing both localized tissue damage and systemic repair processes, making the blend a subject of significant interest in tissue regeneration and injury recovery research.
Key Benefits
- Comprehensive tissue repair
- Synergistic healing
- Muscle and tendon recovery
- Gut healing
- Reduced inflammation
- Convenience of single injection
Mechanism of Action
- Combines BPC-157 and TB-500 mechanisms
- BPC-157: nitric oxide, fibroblast activation
- TB-500: actin regulation, angiogenesis
Best For
- Injury recovery research
- Post-surgery research
- Athletes
- Gut health research
Body Systems
🐾 Griffin Says...
Molecular Information
Molecular weight
BPC-157: 1419.535 g/mol; TB-500: 4963.44 g/mol
Length
BPC-157: 15 amino acids; TB-500: 43 amino acids
Type
Synthetic Peptide Blend
Amino acid sequence
BPC-157: GEPPPGKPADDAGLV (Glycine-Glutamic acid-Proline-Proline-Proline-Glycine-Lysine-Proline-Alanine-Aspartic acid-Aspartic acid-Alanine-Glycine-Leucine-Valine); TB-500: Ac-LSKLEKKTETQEKNTLPKESLPSETTVDKKEKLTES-OH (N-acetyl-Lysine-Serine-Leucine-Glutamic acid-Lysine-Lysine-Threonine-Glutamic acid-Threonine-Glutamic acid-Lysine-Arginine-Threonine-Arginine-Lysine-Serine-Leucine-Proline-Glutamic acid-Serine-Glutamic acid-Glutamic acid-Threonine-Threonine-Valine-Aspartic acid-Lysine-Lysine-Glutamic acid-Lysine-Leucine-Threonine-Glutamic acid-Serine-Threonine-OH)
TB-500 sequence is often presented as Ac-SDKP, the active site, but the full sequence as a synthetic fragment of Thymosin Beta 4 is LKSKLEKKTETQEKN...
Research Indications
Comprehensive Tissue Repair
Research indicates a synergistic effect of BPC-157's localized healing and TB-500's systemic repair capabilities for various tissues including muscle, tendon, ligament, and bone.
Accelerated Injury Recovery
Numerous studies in animal models suggest enhanced healing rates for acute and chronic injuries, attributed to increased angiogenesis, collagen synthesis, and cell migration.
Reduced Inflammation
Both peptides have shown anti-inflammatory properties in research, potentially contributing to faster recovery and pain reduction post-injury.
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General Injury Recovery / Tissue Repair | 250 mcg BPC-157 and 250 mcg TB-500 | Once daily | Subcutaneous (systemic or near injury) |
| Accelerated Healing for Acute Injuries (e.g., muscle tear, sprain) | 250 mcg BPC-157 and 250 mcg TB-500 | Twice daily | Subcutaneous (localized near injury) |
| Chronic Tendon/Ligament Issues | 500 mcg BPC-157 and 500 mcg TB-500 | Once daily | Subcutaneous (localized near affected area) |
| Gut Health / Inflammatory Bowel Conditions | 250 mcg BPC-157 and 250 mcg TB-500 | Once daily | Subcutaneous (abdominal area) |
| Post-Surgical Recovery Enhancement | 250-500 mcg BPC-157 and 250-500 mcg TB-500 | Once daily | Subcutaneous (systemic or near surgical site) |
Research protocols often suggest administering injections around the same time daily for consistent systemic exposure. For localized injuries, administration near the injury site is commonly discussed.
Peptide Interactions
- Monitor Combination
Corticosteroids
Corticosteroids can inhibit healing and inflammation, potentially counteracting the beneficial effects of BPC-157 and TB-500 on tissue repair and inflammation modulation. Research suggests caution and monitoring.
- Monitor Combination
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
While BPC-157 can counteract some of the gastrointestinal damage induced by NSAIDs, the anti-inflammatory action of NSAIDs might partially overlap or interfere with the peptides' mechanisms. Closely observe for desired effects.
- Synergistic
Growth Hormone (GH) / GH Secretagogues
The combination is often discussed as potentially synergistic, as GH/secretagogues promote overall growth and repair, which could be complemented by the targeted healing effects of BPC-157 and TB-500.
- Compatible
Other Regenerative Peptides (e.g., GHK-Cu, CJC-1295/Ipamorelin)
Often researched in combination with other peptides aimed at regeneration or growth hormone release. No direct negative interactions are commonly reported, but cumulative effects should be monitored.
- Use Caution
Immunosuppressants
Given TB-500's potential immunomodulatory effects, combining with immunosuppressants might require careful consideration and monitoring for altered immune responses. Further research is needed.
How to Reconstitute
- 1Gather supplies: BPC-157 + TB-500 blend vial, bacteriostatic water vial, sterile syringes (e.g., insulin syringes), alcohol wipes.
- 2Remove plastic caps from both peptide and bacteriostatic water vials.
- 3Clean rubber stoppers of both vials with alcohol wipes and allow to air dry.
- 4Draw the desired amount of bacteriostatic water into a sterile syringe. Common dilution ratios are 1-2 ml per 5mg vial for ease of dosing.
- 5Slowly inject the bacteriostatic water into the BPC-157 + TB-500 blend vial, directing the stream against the glass wall to prevent foaming.
- 6Do not shake the vial. Gently swirl the vial between your fingers until the powder is completely dissolved. This may take a few minutes. If undissolved particles remain, continue swirling gently. Some blends may have slight particulate matter even after full dissolution which is common.
Always use bacteriostatic water for reconstitution to extend shelf life. Avoid shaking; gently swirl to mix.
What to Expect
- Weeks 1-2: Initial reduction in localized pain or discomfort, subtle improvements in tissue resilience.
- Weeks 2-4: Noticeable improvements in injury recovery, enhanced mobility, or reduction in inflammation markers.
- Weeks 4-6: Significant progress in tissue repair, improved functional capacity, and potential benefits in gut health or systemic well-being.
- Weeks 6-8: Sustained and robust healing, often with improved strength and recovery times from physical exertion.
- Post-cycle: Continued benefits may be observed for several weeks after the cessation of administration, particularly for sustained tissue regeneration.
Side Effects & Safety
| Effect | Frequency | Severity |
|---|---|---|
| See BPC-157 and TB-500 individual profiles | Combined | Mild |
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open CalculatorPeptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.